Literature DB >> 11023984

Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells.

C Napoli1, O Quehenberger, F De Nigris, P Abete, C K Glass, W Palinski.   

Abstract

Apoptosis of arterial cells induced by oxidized low density lipoproteins (OxLDL) is thought to contribute to the progression of atherosclerosis. However, most data on apoptotic effects and mechanisms of OxLDL were obtained with extensively oxidized LDL unlikely to occur in early stages of atherosclerotic lesions. We now demonstrate that mildly oxidized LDL generated by incubation with oxygen radical-producing xanthine/xanthine oxidase (X/XO) induces apoptosis in primary cultures of human coronary endothelial and SMC, as determined by TUNEL technique, DNA laddering, and FACS analysis. Apoptosis was markedly reduced when X/XO-LDL was generated in the presence of different oxygen radical scavengers. Apoptotic signals were mediated by intramembrane domains of both Fas and tumor necrosis factor (TNF) receptors I and II. Blocking of Fas ligand (FasL) reduced apoptosis by 50% and simultaneous blocking of FasL and TNF receptors by 70%. Activation of apoptotic receptors was accompanied by an increase of proapoptotic and a decrease in antiapoptotic proteins of the Bcl-2 family and resulted in marked activation of class I and II caspases. Mildly oxidized LDL also activated MAP and Jun kinases and increased p53 and other transcription factors (ATF-2, ELK-1, CREB, AP-1). Inhibitors of Map and Jun kinase significantly reduced apoptosis. Our results provide the first evidence that OxLDL-induced apoptosis involves TNF receptors and Jun activation. More important, they demonstrate that even mildly oxidized LDL formed in atherosclerotic lesions may activate a broad cascade of oxygen radical-sensitive signaling pathways affecting apoptosis and other processes influencing the evolution of plaques. Thus, we suggest that extensive oxidative modifications of LDL are not necessary to influence signal transduction and transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023984     DOI: 10.1096/fj.99-0986com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

Review 1.  The effect of chronic kidney disease on lipid metabolism.

Authors:  Neris Dincer; Tuncay Dagel; Baris Afsar; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

2.  Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells.

Authors:  Shu-Er Chow; Wing-Keung Chu; Stephen H Shih; Jan-Kan Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

3.  Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Authors:  Zufeng Ding; Shijie Liu; Bo Yang; Yubo Fan; Xiaoyan Deng
Journal:  J R Soc Interface       Date:  2011-11-02       Impact factor: 4.118

4.  The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Sampath Parthasarathy; Patrice Delafontaine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

Review 5.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

Review 6.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

7.  Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.

Authors:  Claudio Napoli; Eric Ackah; Filomena De Nigris; Piero Del Soldato; Francesco P D'Armiento; Ettore Crimi; Mario Condorelli; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

8.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coe van Solingen; C Fernández-Hernando; Y Suárez
Journal:  Curr Vasc Pharmacol       Date:  2013-05-13       Impact factor: 2.719

9.  Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells.

Authors:  Roberto Vicinanza; Giuseppe Coppotelli; Carolina Malacrino; Tiziana Nardo; Barbara Buchetti; Luisa Lenti; Francesco S Celi; Susanna Scarpa
Journal:  Thyroid       Date:  2013-02       Impact factor: 6.568

10.  Pleiotropic vasoprotective effects of statins: the chicken or the egg?

Authors:  Dimitrios Kirmizis; Dimitrios Chatzidimitriou
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.